- Home
- MDCX vs CIIT Comparison
MDCX vs CIIT Comparison
Compare MDCX & CIIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDCX
- CIIT
- Stock Information
- Founded
- MDCX 2008
- CIIT N/A
- Country
- MDCX Canada
- CIIT Hong Kong
- Employees
- MDCX N/A
- CIIT N/A
- Industry
- MDCX
- CIIT
- Sector
- MDCX
- CIIT
- Exchange
- MDCX Nasdaq
- CIIT NYSE
- Market Cap
- MDCX 44.0M
- CIIT 36.0M
- IPO Year
- MDCX N/A
- CIIT N/A
- Fundamental
- Price
- MDCX $3.10
- CIIT $1.23
- Analyst Decision
- MDCX Strong Buy
- CIIT
- Analyst Count
- MDCX 2
- CIIT 0
- Target Price
- MDCX $23.50
- CIIT N/A
- AVG Volume (30 Days)
- MDCX 482.2K
- CIIT 319.8K
- Earning Date
- MDCX 08-22-2025
- CIIT 06-09-2025
- Dividend Yield
- MDCX N/A
- CIIT N/A
- EPS Growth
- MDCX N/A
- CIIT N/A
- EPS
- MDCX N/A
- CIIT N/A
- Revenue
- MDCX N/A
- CIIT $9,464,501.00
- Revenue This Year
- MDCX N/A
- CIIT N/A
- Revenue Next Year
- MDCX N/A
- CIIT N/A
- P/E Ratio
- MDCX N/A
- CIIT N/A
- Revenue Growth
- MDCX N/A
- CIIT 51.52
- 52 Week Low
- MDCX $1.80
- CIIT $0.56
- 52 Week High
- MDCX $8.94
- CIIT $5.38
- Technical
- Relative Strength Index (RSI)
- MDCX N/A
- CIIT N/A
- Support Level
- MDCX N/A
- CIIT N/A
- Resistance Level
- MDCX N/A
- CIIT N/A
- Average True Range (ATR)
- MDCX 0.00
- CIIT 0.00
- MACD
- MDCX 0.00
- CIIT 0.00
- Stochastic Oscillator
- MDCX 0.00
- CIIT 0.00
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About CIIT TIANCI INTERNATIONAL INC
Tianci International Inc along with its subsidiaries is engaged in sale of components of electronic devices, development of software and websites, technical consulting, and providing maintenance support on customized software. The company's business is predominantly carried out in Hong Kong with a substantial portion of its overall revenue being generated from its Electronic Device Hardware Components Sales segment.